Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association studies of COVID-19 vaccine seroconversion and breakthrough outcomes in UK Biobank.

Nature communications - 9 Oct 2024

Alcalde-Herraiz Marta, Català Martí, Prats-Uribe Albert, Paredes Roger, Xie JunQing, Prieto-Alhambra Daniel

Abstract excerpt

Understanding the genetic basis of COVID-19 vaccine seroconversion is crucial to study the role of genetics on vaccine effectiveness. In our study, we used UK Biobank data to find the genetic determinants of COVID-19 vaccine-induced seropositivity and breakthrough infections. We conducted four genome-wide association studies among vaccinated participants for COVID-19 vaccine seroconversion and breakthrough...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Biological Specimen Banks

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Vaccines

Share to SARS-CoV-2

Share to UK Biobank

Share to United Kingdom

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 39384777
DOI: 10.1038/s41467-024-52890-6
PMCID: PMC11464770

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association studies of COVID-19 vaccine seroconversion and breakthrough outcomes in UK Biobank.PMID 39384777Read ↗

Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes.Semantic proximity Read ↗

HLA Alleles, COVID-19 Vaccine Antibody Response and Real-World Breakthrough OutcomesSemantic proximity Read ↗

How could our genetics impact COVID-19 vaccine response?Semantic proximity Read ↗

Genetic variation in HLA, IGKV and HHEX loci influence mRNA vaccine-induced long-lasting humoral protection against COVID-19Semantic proximity Read ↗

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.Semantic proximity Read ↗

Comprehensive genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections: a prospective, comparative cohort studySemantic proximity Read ↗

Strong humoral response after Covid-19 vaccination correlates with the common HLA allele A*03:01 and protection from breakthrough infection.Semantic proximity Read ↗

Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity.Semantic proximity Read ↗

Genetic determinants of IgG antibody response to COVID-19 vaccinationSemantic proximity Read ↗

A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine EffectivenessSemantic proximity Read ↗

COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational varianceSemantic proximity Read ↗

Genome-wide association study of COVID-19 Breakthrough Infections and genetic overlap with other diseases: A study of the UK BiobankSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.